These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27646609)

  • 1. Perilipin 1 is a highly specific marker for adipocytic differentiation in sarcomas with intermediate sensitivity.
    Westhoff CC; Mrozinski J; Riedel I; Heid HW; Moll R
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):225-232. PubMed ID: 27646609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perilipin 1 Expression Differentiates Liposarcoma from Other Types of Soft Tissue Sarcoma.
    Straub BK; Witzel HR; Pawella LM; Renner M; Eiteneuer E; Hashani M; Schirmacher P; Roth W; Mechtersheimer G
    Am J Pathol; 2019 Aug; 189(8):1547-1558. PubMed ID: 31125552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Utility of Perilipin in Liposarcomas: PLIN1 Differentiates Round Cell Liposarcoma From Other Round Cell Sarcomas.
    Compton ML; Al-Rohil RN
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):152-157. PubMed ID: 32205741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate Subtypes.
    Zhang Q; Zhang P; Li B; Dang H; Jiang J; Meng L; Zhang H; Zhang Y; Wang X; Li Q; Wang Y; Liu C; Li F
    J Cancer; 2020; 11(14):4081-4090. PubMed ID: 32368290
    [No Abstract]   [Full Text] [Related]  

  • 5. Scavenger Receptor Class B Type 1 (SR-B1) being a Potential Biomarker for the Diagnosis of Liposarcoma and Associated with the Degree of Differentiation of Liposarcomas.
    Liu Q; Li Z; Shang H; Zhang Q; Wang X; Zhang Y; Wang Y; Li Q; Li C; Liu C; Li F
    J Cancer; 2019; 10(18):4326-4332. PubMed ID: 31413752
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of endothelial area with VEGF-A, COX-2, maspin, c-KIT, and DOG-1 immunoreactivity in liposarcomas versus non-lipomatous soft tissue tumors.
    Jung I; Gurzu S; Turdean S; Ciortea D; Sahlean DI; Golea M; Bara T
    Int J Clin Exp Pathol; 2015; 8(2):1776-82. PubMed ID: 25973067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
    Hisaoka M; Matsuyama A; Nakamoto M
    Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue liposarcoma: histological subtypes, MRI and CT findings.
    Barile A; Zugaro L; Catalucci A; Caulo M; Di Cesare E; Splendiani A; Gallucci M; Masciocchi C
    Radiol Med; 2002 Sep; 104(3):140-9. PubMed ID: 12471362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis.
    Straub BK; Herpel E; Singer S; Zimbelmann R; Breuhahn K; Macher-Goeppinger S; Warth A; Lehmann-Koch J; Longerich T; Heid H; Schirmacher P
    Mod Pathol; 2010 Mar; 23(3):480-92. PubMed ID: 20081801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
    Chamberlain FE; Wilding C; Jones RL; Huang P
    Expert Opin Investig Drugs; 2019 Jun; 28(6):505-511. PubMed ID: 31010343
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical staining for adipophilin, perilipin and TIP47.
    Muthusamy K; Halbert G; Roberts F
    J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of the immunohistochemical expression of perilipin 1 and adipophilin in high-grade liposarcoma.
    Kawaguchi K; Kohashi K; Mori T; Yamamoto H; Iwasaki T; Kinoshita I; Susuki Y; Furukawa H; Endo M; Matsumoto Y; Nakashima Y; Oda Y
    J Clin Pathol; 2023 May; ():. PubMed ID: 37258253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
    J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subfascial lipomatous tumors: management in a series of 37 consecutive cases].
    Gouin F; Bertrand-Vasseur A; Collet T; Moreau A; Leaute F; Rolland F; Cussac A; Passuti N
    Rev Chir Orthop Reparatrice Appar Mot; 2001 Oct; 87(6):585-95. PubMed ID: 11685150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adipocytic tumors].
    Stock N
    Ann Pathol; 2015 Jan; 35(1):41-53. PubMed ID: 25533918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
    Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
    J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.